Dsuvia
Product Images NDC 61621-430

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dsuvia (NDC 61621-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acelrx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sufentanil-figure-01 (Sufentanil Figure 01)

An instructional illustration labeled Figure 1 depicting the contents of a Dsuvia pouch. It shows a clear plastic single-dose applicator (SDA) containing a blue-colored tablet housed in the tip. The components include a lock pusher, the SDA, the tablet, and a separate oxygen absorber packet. The illustration is part of medication administration instructions.*

FDA Label Image

Sufentanil-figure-02 (Sufentanil Figure 02)

Illustrations showing the lock removal process for Dsuvia. The first image depicts a hand squeezing and detaching the white lock from the green pusher. The second shows the green pusher and tablet assembly, with a hand removing the lock. The text provides instructions to remove and discard the lock before administration and precautions to avoid accidental ejection of the tablet.*

FDA Label Image

Sufentanil-figure-03 (Sufentanil Figure 03)

Instructional illustrations showing the placement of Dsuvia tablet sublingually. One diagram depicts the SDA device positioning the tablet under the tongue in the sublingual space, with labeled mouth, tongue, and sublingual space. Another shows visual confirmation of the tablet in the sublingual space inside an open mouth.*

FDA Label Image

Sufentanil-figure-04 (Sufentanil Figure 04)

A line graph depicting plasma concentration (pg/mL) over time post-dose (hours) for Dsuvia 30 mcg single dose and multiple dose. The x-axis represents time up to 36 hours post-dose, and the y-axis shows plasma concentration levels. The graph includes error bars indicating variability in measurements.*

FDA Label Image

Sufentanil-figure-05 (Sufentanil Figure 05)

A line graph comparing the PID LS mean (SEM) over 24 hours for Dsuvia 30 mcg (N=107) and Placebo (N=54). The x-axis represents time in hours from 0 to 24, and the y-axis shows the PID LS mean (SEM) ranging approximately from -1 to 4. Two lines depict the measurements for each group, with Dsuvia generally showing higher values than the placebo over the time course.*

FDA Label Image

Sufentanil-figure-06 (Sufentanil Figure 06)

Chemical structure diagram showing the molecular structures of Sufentanil and Citrate. The image labels both chemical compounds clearly with their respective molecule illustrations.*

FDA Label Image

Sufentanil-figure-07 (Sufentanil Figure 07)

Dsuvia (sufentanil) sublingual tablet 30 mcg packaging label showing a carton for 10 single-dose applicators. The label includes storage instructions, warnings, inactive ingredients, and manufacturing details by AcelRx Pharmaceuticals, Inc. Barcode and NDC number 61621-430-11 are also visible.*

FDA Label Image

Sufentanil-figure-08 (Sufentanil Figure 08)

Instructions for use of Dsuvia (sufentanil sublingual tablet 30 mcg) in a single-use pouch. The diagram shows how to open the pouch, remove the tablet from the oxygen absorber packet, unlock and operate the delivery pusher, and correctly place the tablet in the patient's sublingual space beneath the tongue. Key safety notes include not reusing the applicator or pouch if damaged, avoiding touching the tablet before administration, and disposing of used materials following safety protocols.*

FDA Label Image

Sufentanil-figure-09 (Sufentanil Figure 09)

This panel from Dsuvia provides directions for use and lists inactive ingredients, including mannitol, dicalcium phosphate anhydrous, and others. It includes a contact number for questions, manufacturer information for AcelRx Pharmaceuticals, and a QR code linking to additional product details and instructional videos on the official website.*

FDA Label Image

Sufentanil-figure-10.jpg (Sufentanil Figure 10)

The image displays an inactive ingredients panel for Dsuvia, listing mannitol, dicalcium phosphate anhydrous, hydroxypropyl methylcellulose, croscarmellose sodium, FD&C Blue #2, stearic acid, and magnesium stearate. It includes a contact phone number for questions, the manufacturer AcelRx Pharmaceuticals, Inc., and a note with a website link for additional information and an instructional video.*

FDA Label Image

Sufentanil-figure-11 (Sufentanil Figure 11)

Dsuvia (sufentanil) sublingual tablet 30 mcg packaging label from AcelRx Pharmaceuticals, Inc. The label shows the NDC number 61621-430-01, instructions for use including dosing limits, storage conditions, and a note that the product is Rx only. It also mentions the requirement for administration by a healthcare provider in a certified setting and cautions on patient instructions for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.